23andMe

23andMe is a human genome research company enabling users to study their ancestry, genealogy, and inherited traits.

A startup co-founded by Linda Avey and Anne Wojcicki, the wife of Google co-founder Sergey Brin, 23andMe has plans to make the human genome searchable. Brin, along with Google, gave 23andMe $3.9 million as part of a series A in May of 2007.

The company was named after the number of chromosome pairs in humans. They aim to help people understand what their genes mean by indexing them and highlighting significant findings.

23andMe allows its clients/users to study their ancestry, genealogy and inherited traits. The company also markets to researchers and scientists, for whom they provide neatly categorized and easily searchable data.

One reason the Google investment in 23andMe made sense was that this company could enable the search giant to index another facet of the world's information. With the Biotech and Health Care industries growing rapidly, 23andMe could help Google get and maintain a market hold in these already multi-billion dollar areas.

23andMe, established in 2006 and headquartered in United States, North America., specializes in Early Stage Venture investments across Software, Mobile Apps, Health Care, Virtualization, Hospital, Telehealth, Venture Capital, Finance, Business Development, Financial Services. The organization boasts a portfolio of 2 investments, with an average round size of $53.4M and 1 successful exits. Their recent investments include Doctor On Demand, Qualcomm Ventures, Virgin Group, Venrock, Shasta Ventures. The highest investment round they participated in was $14.7B. Among their most notable exits are Doctor On Demand and Qualcomm Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.